Protein Chip Market Type, Product, Application and Growth Forecast to 2032 | MRFR
Protein Chip Market Highlights
According
to MRFR analysis, the global protein chip market size was
valued at USD 1.1 Billion in 2022. The protein chip market industry is
projected to grow from USD 1.17 Billion in 2023 to USD 1.973 Billion by 2032,
exhibiting a compound annual growth rate (CAGR) of 6.71% during the forecast
period (2023 - 2032).
The global
protein chip market is driven by several factors, such as rising incidences and
prevalence of cancer, developments in protein chip assays, and the increasing
application of protein chips in infectious disease. There is an increasing
prevalence of infectious diseases such as coronavirus, chickenpox, dengue, and
diphtheria across the globe. There are numerous methods used to diagnose and
treat infectious diseases in patients. The protein chip technology enhances the
efficiency in diagnosing various diseases. It plays an increasingly important
role in the discovery of diagnostic markers, vaccines, and therapeutics for
infectious diseases. For instance, a protein chip is being used for displaying
peptides and proteins representing antigens from SARS-CoV-2 as well as other
coronaviruses.
The players
in the global protein chip market are focusing on new product development,
partnerships, and acquisitions. For instance, in March 2022, Sengenics launched
the i-Ome Protein Array Kit with KREX technology that will help researchers
identify autoantibody biomarkers.
Regional
Analysis
North
America is likely to dominate the market of protein chip, owing to the rise in
the number of cancer patients and the well-developed healthcare infrastructure
in the region. For instance, according to the Centers for Disease Control and
Prevention, in the year 2019, a large number of cancer cases were reported in
the US. Additionally according to Canadian Cancer Statistics, 2 in 5 Canadians
are predicted to receive a cancer diagnosis during their lifetime, and 1 in 4
will die from the disease. These factors are fueling the expansion of the
region's protein chip market.
Europe is
likely to account for a significant market share in the protein chip due to
increasing government initiatives and funding in genomic and proteomic
research. For instance, in April 2022, the Danish National Genome Center
partnered with Lifebit to deliver nationwide personalised medicine.
Asia-Pacific
is projected to be the fastest-growing regional market during the forecast
period due to factors such as high demand for protein chips in various
diagnostic applications and a rise in the awareness of personalized medicine in
the region. Similarly, the COVID-19 pandemic augmented the demand for protein
chip technology across research laboratories and academic institutes throughout
the region.
Furthermore,
the growth of the market in the rest of the world is slower compared to the
other regions due to the lack of healthcare infrastructure and limited research
activities. However, the cost effectiveness of the protein chip technology is
expected to drive the regional protein chip market.
Segmentation
The global protein chip market outlook has been
segmented into type, application and end user.
Based on
type, the market has been segmented into analytical microarrays, functional
protein microarrays, and reverse phase protein microarrays. The
analytical microarrays segment expected the
largest market share in 2021 due to an increase in the adoption of analytical
microarrays by leading pharmaceutical and biopharmaceutical companies for
various applications.
Based on
application, the market has been segmented into protein identification,
clinical diagnostics, proteomics, and others. The protein identification
segment expected the largest share of the market in 2021 due to the increasing
use of protein chips for capturing and measuring proteins from biologic
samples.
Based on
end users, the market has been segmented into hospitals & clinics,
diagnostic laboratories, academic & research institutes, and pharmaceutical
& biotechnology companies. Academic and research institutes expected the
largest market share in 2021 due to a rise in the use of microarrays in drug discovery and research applications.
Key Players
Some of the
key market players are Sengenics (US), Thermo Fisher Scientific Inc. (US),
Microarrays Inc. (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories,
Inc. (US), Full Moon BioSystems, Inc. (US), CDI Laboratories Inc. (US), OriGene
Technologies, Inc. (US) and Innopsys (France).
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact
us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street, 5Th Floor,
New
York, New York 10013
United
States of America
+1
628 258 0071
Email:
sales@marketresearchfuture.com
Comments
Post a Comment